ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.

Epinephrine nasal spray is usually given at the first sign of an allergic reaction. BPI Labs and Endo USA nasal solutions products should never be injected intravenously, FDA warned.

unaudited neffy ® (epinephrine nasal spray) net product revenue for the fourth quarter and full year 2024 and outlined its 2025 commercial and clinical objectives. The preliminary results set ...

neffyinSchools provides eligible public and private K-12 schools in the U.S. with the opportunity to receive two cartons (four single use doses) of neffy ® (epinephrine nasal spray) 2 mg for use ...

School administrators and nurses are encouraged to review applicable state laws and regulations to ensure neffy ® (epinephrine nasal spray) 2 mg for undesignated use meets applicable state law ...